aranesp darbepoetin alpha (rch) 60 microgram/0.3ml injection syringe within a pen injector
amgen australia pty ltd - darbepoetin alfa, quantity: 200 microgram/ml - injection, solution - excipient ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; sodium chloride; polysorbate 80; water for injections - aranesp is indicated for the treatment of anaemia associated with chronic renal failure (crf). aranesp is also indicated for the treatment of anaemia and reduction of transfusion requirements in patients with non-myeloid malignacies where anaemia develops as a result of concommitantly administered chemotherapy.
nesp injection plastic syringe 60 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
nesp injection plastic syringe 20 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
nesp injection plastic syringe 30 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
nesp injection plastic syringe 120 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
nesp injection plastic syringe 180 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
nesp injection plastic syringe 10 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
nesp injection plastic syringe 40 mcg0.5ml
kyowa kirin malaysia sdn. bhd. - darbepoetin alfa; darbepoetin alfa -
epoetin alfa bs injection 1500 syringe "jcr" [anemia of prematurity] (エポエチンアルファbs注1500シリンジ「jcr」[未熟児貧血])
kissei pharmaceutical co., ltd. - epoetin kappa (genetical recombination) [epoetin alfa biosimilar 1] - injection
epoetin alfa bs injection 3000 syringe "jcr" [anemia of prematurity] (エポエチンアルファbs注3000シリンジ「jcr」[未熟児貧血])
kissei pharmaceutical co., ltd. - epoetin kappa (genetical recombination) [epoetin alfa biosimilar 1] - injection